Projects funded by the NCN
NADPH oxidase genes expression in peripheral blood mononuclear cells (PBMC) in anti-TNF alpha-treated rheumatoid arthritis patients and its impact on type I interferon activity, clinical outcome and treatment response.
2018/31/N/NZ5/03023
Keywords:
NADPH oxidase gene expression anti-TNF alpha treatment
Descriptors:
- NZ5_7: Human disease treatment
- NZ5_3: Pathogenesis of human diseases
Panel:
NZ5 - Human and animal noninfectious diseases: etiology, mechanisms, diagnosis and treatment of diseases, poisonings and injuries (without neurological diseases)
Host institution :
Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji im. prof. dr hab. med. Eleonory Reicher
woj. mazowieckie
Principal investigator (from the host institution):
Number of co-investigators in the project: 3
Call: PRELUDIUM 16 - announced on 2018-09-14
Amount awarded: 207 260 PLN
Project start date (Y-m-d): 2019-07-24
Project end date (Y-m-d): 2023-07-23
Project duration:: 36 months (the same as in the proposal)
Project status: Project completed
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.